List of Excipients in API setmelanotide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing setmelanotide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc | IMCIVREE | setmelanotide | 72829-010 | BENZYL ALCOHOL | 2034-07-04 |
| Rhythm Pharmaceuticals Inc | IMCIVREE | setmelanotide | 72829-010 | CARBOXYMETHYLCELLULOSE | 2034-07-04 |
| Rhythm Pharmaceuticals Inc | IMCIVREE | setmelanotide | 72829-010 | EDETATE DISODIUM | 2034-07-04 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for setmelanotide
Excipient focus: BENZYL ALCOHOL
setmelanotide drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rhythm Pharmaceuticals Inc | setmelanotide | 72829-010 |
| >Company | >Ingredient | >NDC |
setmelanotide drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE
setmelanotide drug variants containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rhythm Pharmaceuticals Inc | setmelanotide | 72829-010 |
| >Company | >Ingredient | >NDC |
setmelanotide drug variants not containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
setmelanotide drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Rhythm Pharmaceuticals Inc | setmelanotide | 72829-010 |
| >Company | >Ingredient | >NDC |
setmelanotide drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
setmelanotide drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Rhythm Pharmaceuticals Inc | setmelanotide | 72829-010 |
| >Company | >Ingredient | >NDC |
setmelanotide drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
setmelanotide drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Rhythm Pharmaceuticals Inc | setmelanotide | 72829-010 |
| >Company | >Ingredient | >NDC |
setmelanotide drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
setmelanotide drug variants containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Rhythm Pharmaceuticals Inc | setmelanotide | 72829-010 |
| >Company | >Ingredient | >NDC |
setmelanotide drug variants not containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch